Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
AbbVie
ABBV
|
$384M |
| 2 |
Microsoft
MSFT
|
$352M |
| 3 |
Intuit
INTU
|
$350M |
| 4 |
ICU Medical
ICUI
|
$295M |
| 5 |
Netflix
NFLX
|
$287M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$673M |
| 2 |
American Tower
AMT
|
$538M |
| 3 |
Apple
AAPL
|
$456M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$436M |
| 5 |
Meta Platforms (Facebook)
META
|
$384M |
Sector Composition
| 1 | Technology | 23.85% |
| 2 | Healthcare | 17.84% |
| 3 | Financials | 12.82% |
| 4 | Industrials | 11.63% |
| 5 | Consumer Discretionary | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Neurocrine Biosciences
NBIX
$13.8B
| $629M | 0.4% |
8,807,414
+1,644,949
| +23% | +$117M |
|
52
LPL Financial
LPLA
$29.2B
| $618M | 0.39% |
10,112,890
+191,209
| +2% | +$11.7M |
|
|
AGN
53
DELISTED
Allergan plc
AGN
| $613M | 0.39% |
4,589,834
+260,962
| +6% | +$34.9M |
|
|
54
ICU Medical
ICUI
$3.15B
| $609M | 0.39% |
2,653,767
+1,282,922
| +94% | +$295M |
|
55
L3Harris
LHX
$51.9B
| $596M | 0.38% |
4,426,229
+1,452,812
| +49% | +$196M |
|
56
Starbucks
SBUX
$102B
| $592M | 0.38% |
9,196,519
-2,460,304
| -21% | -$158M |
|
57
PayPal
PYPL
$66.2B
| $588M | 0.37% |
6,990,180
+1,276,911
| +22% | +$107M |
|
58
Costco
COST
$416B
| $578M | 0.37% |
2,835,260
+714,839
| +34% | +$146M |
|
59
Alibaba
BABA
$330B
| $576M | 0.37% |
4,202,776
-99,507
| -2% | -$13.6M |
|
60
US Bancorp
USB
$76B
| $576M | 0.37% |
12,601,216
+682,996
| +6% | +$31.2M |
|
61
Air Products & Chemicals
APD
$65.5B
| $567M | 0.36% |
3,543,659
-467,401
| -12% | -$74.8M |
|
|
TMX
62
DELISTED
Terminix Global Holdings, Inc.
TMX
| $565M | 0.36% |
15,378,109
+1,617,787
| +12% | +$59.4M |
|
63
Lamar Advertising Co
LAMR
$12.9B
| $558M | 0.36% |
8,072,425
-148,774
| -2% | -$10.3M |
|
64
Nice
NICE
$8.73B
| $554M | 0.35% |
5,119,095
+34,902
| +0.7% | +$3.78M |
|
65
Sherwin-Williams
SHW
$91.2B
| $542M | 0.35% |
1,377,122
+37,851
| +3% | +$14.9M |
|
66
Aon
AON
$79.1B
| $538M | 0.34% |
3,698,181
-86,831
| -2% | -$12.6M |
|
67
Thermo Fisher Scientific
TMO
$186B
| $537M | 0.34% |
2,401,096
+366,942
| +18% | +$82.1M |
|
68
Elevance Health
ELV
$71.8B
| $536M | 0.34% |
2,039,724
+619,679
| +44% | +$163M |
|
69
WEX
WEX
$5.87B
| $532M | 0.34% |
3,795,653
-52,237
| -1% | -$7.32M |
|
70
Johnson & Johnson
JNJ
$429B
| $527M | 0.34% |
4,080,516
-333,210
| -8% | -$43M |
|
71
ON Semiconductor
ON
$20.3B
| $504M | 0.32% |
30,534,147
-89,857
| -0.3% | -$1.48M |
|
72
Revvity
RVTY
$10.5B
| $501M | 0.32% |
6,375,413
+168,503
| +3% | +$13.2M |
|
73
Cisco
CSCO
$268B
| $501M | 0.32% |
11,540,505
+53,024
| +0.5% | +$2.3M |
|
|
NATI
74
DELISTED
National Instruments Corp
NATI
| $499M | 0.32% |
11,005,691
-381,251
| -3% | -$17.3M |
|
75
Norwegian Cruise Line
NCLH
$11.2B
| $494M | 0.32% |
11,665,232
+662,906
| +6% | +$28.1M |
|